Our Pricing

Buy Wegovy UK: Next Day Delivery Once Approved

Published on: June 03, 2026

When you buy Wegovy UK next day delivery through Cured Pharmacy, you receive genuine semaglutide injections from £79.00, prescribed by UK-registered clinicians following a free online consultation that takes under three minutes. Once your prescription is approved, your medication is dispatched discreetly with next day delivery options available across the UK.

How Wegovy Semaglutide Works for Weight Loss

Wegovy contains semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist licensed by the MHRA for chronic weight management in adults with a BMI of 30 kg/m² or greater, or 27 kg/m² with at least one weight-related comorbidity [1]. Semaglutide mimics the action of GLP-1, a naturally occurring hormone that regulates appetite and food intake by acting on receptors in the brain that control hunger signals.

In the landmark STEP 1 clinical trial, participants receiving once-weekly semaglutide 2.4 mg achieved an average weight reduction of 14.9% over 68 weeks, compared to 2.4% with placebo [1]. The medication works by slowing gastric emptying, reducing appetite, and increasing feelings of fullness after meals, helping patients adhere to reduced-calorie diets more effectively.

Wegovy is administered as a subcutaneous injection once weekly using a pre-filled pen device. The dosing schedule begins at 0.25 mg weekly and gradually escalates over 16 to 20 weeks to the maintenance dose of 2.4 mg, minimising gastrointestinal side effects commonly associated with GLP-1 therapies [2].

Who Can Buy Wegovy Online in the UK

Wegovy is a prescription-only medication in the UK, meaning you cannot purchase it without a valid prescription from a UK-registered prescriber. At Cured Pharmacy, our clinical team assesses your eligibility through a comprehensive online consultation that reviews your medical history, current medications, and weight management goals.

You may be suitable for Wegovy if you are an adult with a BMI of 30 kg/m² or above, or a BMI of 27 kg/m² or above with at least one weight-related health condition such as type 2 diabetes, hypertension, or obstructive sleep apnoea [3]. Wegovy is not suitable for individuals with a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or those who are pregnant or breastfeeding.

Our superintendent pharmacist Tarun Kumar (GPhC 2233073) and the UK clinical team review every consultation to ensure Wegovy is clinically appropriate and safe for you. If Wegovy is not suitable, alternative weight management treatments may be recommended based on your individual circumstances.

Medical Assessment Process

The online consultation takes under three minutes to complete and covers essential health questions including your weight history, previous weight loss attempts, current medications, and any contraindications. Once submitted, a UK prescriber reviews your answers within hours during working days. If approved, your prescription is sent electronically to our dispensary, and your Wegovy pens are prepared for dispatch with next day delivery options available.

Understanding Wegovy Pricing and Dosing

At Cured Pharmacy, Wegovy is priced from £79.00 per pen, offering transparent upfront costs before you complete your consultation. This pricing reflects our commitment to providing the lowest prices guaranteed in the UK for genuine, UK-licensed semaglutide injections.

The total monthly cost depends on your prescribed dose. During the initial titration phase, you begin with lower doses (0.25 mg, 0.5 mg, 1 mg, 1.7 mg) before reaching the maintenance dose of 2.4 mg. Each pen contains four weekly doses at the prescribed strength, and your prescriber will determine the appropriate escalation schedule based on your tolerance and response to treatment [2].

Unlike some online providers, Cured Pharmacy displays all treatment costs before you begin the consultation process, ensuring complete transparency. There are no hidden fees, and delivery costs are clearly stated at checkout. Our clinical team will never pressure you to purchase higher doses than clinically necessary.

Dose Escalation Schedule

The recommended dose escalation follows a structured protocol: 0.25 mg weekly for four weeks, then 0.5 mg weekly for four weeks, followed by 1 mg weekly for four weeks, then 1.7 mg weekly for four weeks, and finally 2.4 mg weekly as the maintenance dose [2]. This gradual increase helps your body adjust to semaglutide and significantly reduces the risk of gastrointestinal side effects such as nausea and vomiting.

Next Day Delivery Options for Wegovy UK

Once your prescription is approved by a UK prescriber, Cured Pharmacy offers next day delivery across the UK, subject to order placement before our daily dispatch cut-off time. All medications are dispatched from our GPhC-registered pharmacy (registration number 9012511) in 100% discreet packaging with no external indication of contents.

Standard delivery typically arrives within 2-3 working days, while next day delivery ensures you receive your Wegovy pens the following working day when ordered before the cut-off. All deliveries require a signature upon receipt to ensure secure handling of prescription medications. Tracking information is provided automatically once your order is dispatched.

We understand that timely access to weight management medication is important for maintaining treatment adherence and achieving your health goals. Our streamlined prescription approval and dispatch process means most patients receive their Wegovy within 24-48 hours of consultation approval, faster than typical NHS prescription pathways or high-street pharmacy waiting times.

Wegovy Side Effects and Safety Information

Like all GLP-1 receptor agonists, Wegovy may cause side effects, although not everyone experiences them. The most commonly reported side effects are gastrointestinal and include nausea, diarrhoea, vomiting, constipation, and abdominal pain [1]. These effects are typically mild to moderate in severity and tend to diminish as your body adjusts to the medication, particularly when following the recommended dose escalation schedule.

In clinical trials, approximately 7% of participants discontinued Wegovy due to gastrointestinal side effects, compared to 3% in the placebo group [1]. To minimise these effects, take Wegovy consistently on the same day each week, stay well hydrated, eat smaller meals, and avoid high-fat foods during the initial titration phase.

Serious but rare side effects include pancreatitis, gallbladder problems, kidney injury, allergic reactions, and changes in vision in patients with type 2 diabetes. Wegovy carries a boxed warning regarding thyroid C-cell tumours observed in rodent studies, though human relevance remains unclear [3]. You should seek immediate medical attention if you experience severe abdominal pain, persistent vomiting, signs of pancreatitis, or symptoms of an allergic reaction.

Before starting Wegovy, inform your prescriber of all current medications, particularly insulin or other diabetes medications, as semaglutide may increase the risk of hypoglycaemia when used concurrently. Our clinical team at Cured Pharmacy reviews all potential drug interactions during your consultation to ensure safe prescribing.

Managing Common Side Effects

If you experience nausea during the first few weeks, try eating smaller, more frequent meals rather than three large meals daily. Avoid lying down immediately after eating, choose bland foods, and sip water throughout the day. Most patients find these symptoms resolve within 4-6 weeks as tolerance develops. If side effects persist or become severe, contact your prescriber to discuss dose adjustment or alternative treatment options.

Wegovy vs Other Weight Loss Treatments Available in the UK

The UK market offers several prescription weight loss treatments, each with distinct mechanisms, efficacy profiles, and administration methods. Wegovy represents the current gold standard for pharmacological weight management, demonstrating superior weight loss outcomes compared to earlier GLP-1 therapies in head-to-head trials [4].

Saxenda (liraglutide) is an older GLP-1 receptor agonist requiring daily injections rather than weekly administration. Clinical trials show average weight loss of 8% with liraglutide compared to 15% with semaglutide, though both are effective options depending on patient preference and clinical suitability [4]. Some patients prefer daily injections for more granular dose control, while others value the convenience of once-weekly dosing.

Mounjaro (tirzepatide) is a newer dual GIP/GLP-1 receptor agonist licensed in the UK for type 2 diabetes and weight management. Early trial data suggests tirzepatide may produce greater weight loss than semaglutide, with average reductions up to 22.5% in some studies [5]. However, Mounjaro is typically priced higher than Wegovy and may not be suitable for all patients depending on medical history and contraindications.

Oral medications like orlistat work through a completely different mechanism by blocking fat absorption in the intestine, producing more modest weight loss of 5-10% on average. Your UK prescriber will recommend the most appropriate treatment based on your BMI, medical history, previous weight loss attempts, lifestyle factors, and personal preferences regarding injection frequency and side effect profiles.

Choosing Between Injectable and Oral Options

Injectable GLP-1 therapies like Wegovy generally produce greater weight loss than oral alternatives, but require comfort with self-injection and carry a different side effect profile. Patients who cannot tolerate injections or have contraindications to GLP-1 therapies may be better suited to oral medications. Our clinical team provides personalised recommendations during your consultation, considering all relevant factors to identify the optimal treatment for your circumstances.

Scientific References

1. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
2. Novo Nordisk. (2023). Wegovy 2.4 mg Solution for Injection in Pre-filled Pen: Summary of Product Characteristics. Electronic Medicines Compendium. Retrieved from https://www.medicines.org.uk/emc/product/13799 [accessed 13 August 2026]
3. National Institute for Health and Care Excellence. (2023). Semaglutide for Managing Overweight and Obesity: Technology Appraisal Guidance [TA875]. NICE. Retrieved from https://www.nice.org.uk/guidance/ta875 [accessed 13 August 2026]
4. O'Neil, P. M., et al. (2018). Efficacy and Safety of Semaglutide Compared With Liraglutide and Placebo for Weight Loss in Patients With Obesity: A Randomised, Double-Blind, Placebo and Active Controlled, Dose-Ranging, Phase 2 Trial. The Lancet, 392(10148), 637–649. https://doi.org/10.1016/S0140-6736(18)31773-2 [accessed 13 August 2026]
5. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Wegovy is a prescription-only medicine and cannot be supplied without a valid prescription following consultation with a UK clinician.